"Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014
- PMID: 29895275
- PMCID: PMC5998580
- DOI: 10.1186/s12879-018-3158-x
"Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014
Abstract
Background: Timely HIV testing and initiation of antiretroviral therapy are two major determinants of survival for HIV-infected individuals. Our study aimed to explore the trend of late HIV/AIDS diagnoses and to assess the factors associated with these late diagnoses in China between 2006 and 2014.
Methods: We used data from the Chinese Comprehensive Response Information Management System of HIV/AIDS (CRIMS). All individuals who tested positive for HIV between 2006 and 2014 in China and were at least 15 years of age were included. A late diagnosis was defined as an instance in which an individual was diagnosed as having AIDS or WHO stage 3 or 4 HIV/AIDS, or had a CD4 cell count less than 200 cells/mm3 at the time of diagnosis.
Results: Among the 528,234 individuals (≥15 years old) newly diagnosed with HIV between 2006 and 2014, 179,700 (34.0%) people were considered to have received late diagnoses. The late diagnosis rate decreased from 33.9% in 2006 to 29.7% in 2014 (P < 0.01). Late diagnoses were more likely to be found among those who were 45-54 years old (adjusted odds ratio [aOR]: 3.25, 95% confidence interval [CI]: 3.17-3.34) or 55+ years old (OR: 2.94, 95% CI: 2.86-3.02), male (aOR: 1.15, 95% CI: 1.13,1.17), employed as a farmer or rural laborer (aOR: 1.13, 95% CI: 1.11-1.14), infected through blood or plasma transfusion (aOR: 4.18, 95% CI: 4.02, 4.35), diagnosed at hospitals (OR: 1.17, 95% CI: 1.15, 1.19), of Han ethnicity (aOR: 1.30, 95% CI: 1.28, 1.32), and married (OR: 1.12, 95% CI: 1.11,1.13). Of those people living with HIV (PLHIV) who received late diagnoses, 7.4%(8637) and 46.1%(28,462) ultimately died with or without receiving antiretroviral therapy within a year of diagnosis, respectively.
Conclusion: A large proportion of individuals with HIV/AIDS receive late diagnoses, and this proportion has witnessed a slight decline in recent years. Expanded testing is needed to increase early HIV diagnosis and antiretroviral therapy should be recommended to all diagnosed individuals as early as possible to reduce AIDS-related death.
Keywords: ART; China; Early mortality; Late diagnosis.
Conflict of interest statement
Ethics approval and consent to participate
This study was a secondary data analysis using existing Chinese government HIV/AIDS CRIMS data. Therefore, no additional study specific informed consent was necessary for this current study. Patient records and information were de-identified prior to analysis. This study protocol was reviewed and approved by the Institutional Review Board of the National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention (approval #X160310409).
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



Similar articles
-
[An analysis of factors associated with timeliness of antiretroviral therapy initiation among newly diagnosed HIV/AIDS from 2010 to 2014 in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Aug 6;51(8):711-717. doi: 10.3760/cma.j.issn.0253-9624.2017.08.010. Zhonghua Yu Fang Yi Xue Za Zhi. 2017. PMID: 28763920 Chinese.
-
Correlates of Late Presentation to HIV care in a South Indian Cohort.Am J Trop Med Hyg. 2018 Nov;99(5):1331-1335. doi: 10.4269/ajtmh.18-0386. Am J Trop Med Hyg. 2018. PMID: 30226140 Free PMC article.
-
Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.Addiction. 2016 Jul;111(7):1235-45. doi: 10.1111/add.13348. Epub 2016 Apr 14. Addiction. 2016. PMID: 26890155
-
Metabolic Profile of People Living with HIV in a Treatment Hub in Manila, Philippines: A Pre- and Post-Antiretroviral Analysis.J ASEAN Fed Endocr Soc. 2022;37(1):53-61. doi: 10.15605/jafes.037.01.17. Epub 2022 Feb 18. J ASEAN Fed Endocr Soc. 2022. PMID: 35800599 Free PMC article. Review.
-
[Progress on influencing factors of late diagnosis in HIV-infected patients].Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Feb 10;45(2):313-318. doi: 10.3760/cma.j.cn112338-20230908-00142. Zhonghua Liu Xing Bing Xue Za Zhi. 2024. PMID: 38413074 Review. Chinese.
Cited by
-
HIV Late Presenters in Asia: Management and Public Health Challenges.AIDS Res Treat. 2023 Jun 14;2023:9488051. doi: 10.1155/2023/9488051. eCollection 2023. AIDS Res Treat. 2023. PMID: 37351535 Free PMC article. Review.
-
HIV testing behaviors and willingness to receive oral rapid HIV testing among dental patients in Xi'an, China.PLoS One. 2021 Mar 25;16(3):e0248585. doi: 10.1371/journal.pone.0248585. eCollection 2021. PLoS One. 2021. PMID: 33765025 Free PMC article.
-
Concurrent COVID-19 and Pneumocystis jirovecii pneumonia: The importance of radiological diagnostic and HIV testing.Radiol Case Rep. 2021 Oct 2;16(12):3685-3689. doi: 10.1016/j.radcr.2021.09.002. eCollection 2021 Dec. Radiol Case Rep. 2021. PMID: 34630801 Free PMC article.
-
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.J Neurovirol. 2019 Oct;25(5):710-721. doi: 10.1007/s13365-018-0706-5. Epub 2019 Jan 11. J Neurovirol. 2019. PMID: 30635846 Review.
-
Immuno-Diagnostic Interest in Monitoring CD16+CD56+ (Natural Killer) Cells and CD19+CD45+ (B Lymphocytes) in Individuals Newly Diagnosed with HIV in a Tertiary Care Center.J Clin Med. 2024 Feb 18;13(4):1154. doi: 10.3390/jcm13041154. J Clin Med. 2024. PMID: 38398466 Free PMC article.
References
-
- Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17. - PubMed
-
- Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the international AIDS society--USA panel. Top HIV Med. 2006;3:827–843. - PubMed
-
- Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;(13):853–60. - PubMed
-
- Detels R, Muñoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Stud Invest JAMA. 1998;17:1497–1503. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials